The Latest Cardiac and Vascular News
WARRINGTON, Pa., April 27, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT) is a biotechnology company focused on advancing late-stage interventions for acute cardiovascular disorders of acute heart failure and a lead program studying istaroxime in cardiogenic shock. Cardiogenic shock is caused by a failing […]
MANHASSET, N.Y.–(BUSINESS WIRE)–It was a day of celebration and reflection as cardiac doctors, surgeons, nurses and therapists gathered at Sandra Atlas Bass Heart Hospital (SABHH) at North Shore University Hospital (NSUH) on April 26 to celebrate a medial milestone for the health system and region – more than 100 heart transplants have been performed […]
The Heartland Partnership Represents USHV’s First in Kansas. NASHVILLE, Tenn.–(BUSINESS WIRE)–US Heart & Vascular (“USHV”), a leading national provider of support services to cardiovascular physician practices, announced its partnership with Heartland Cardiology (“Heartland”), a Wichita-based cardiovascular physician practice focused on preventative care, diagnostic testing, curative procedures and electrophysiology services. With […]
OXFORD, England, April 26, 2023 /PRNewswire/ — Ultromics, a leader in the field of artificial intelligence-powered diagnostics for heart failure, has been granted FDA Breakthrough Device Status for its AI-enhanced platform for detecting cardiac amyloidosis. The platform, EchoGo Amyloidosis, uses artificial intelligence to analyse echocardiograms and detect the presence of cardiac amyloidosis, a […]
HOPEWELL, N.J., April 26, 2023 /PRNewswire/ — As part of the growing full-service cardiac program available at Capital Health’s Heart and Vascular Institute, physicians and staff from the Institute’s Structural Heart Program recently performed their first transcatheter aortic valve replacement (TAVR) procedure at Capital Health Regional Medical Center in Trenton, New Jersey. TAVR […]
• Mavacamten met the primary endpoint for the treatment of Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy • Mavacamten demonstrated a safety profile consistent with previous studies • If approved, mavacamten is expected to be the first cardiac myosin inhibitor approved in China for the treatment of oHCM • LianBio to host a […]
List recognizes most innovative and impactful digital health solutions that have the potential to make a significant impact in the future. CHICAGO–(BUSINESS WIRE)–Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a precision cardiovascular medicine company, today announced its PrecisionCHD™ test received Juniper Research’s Future Digital Award for the “Best Digital Diagnostics Solution.” Juniper Research’s Future […]
LA ROCHELLE, France–(BUSINESS WIRE)–Regulatory News: Valbiotis (FR0013254851 – ALVAL, PEA / SME eligible) (Paris:ALVAL), a commercially oriented Research and Development company, committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases, announces that its Universal Registration Document was filed to the French Financial Markets Regulator (AMF) April 26, […]
Extending the intellectual property of its fully implantable medical device for restoring cardiac output (ICOMS) BORDEAUX, France–(BUSINESS WIRE)–FineHeart S.A, a medical device company developing the FLOWMAKER®, a fully implantable cardiac output restoration system (ICOMS) to address the unmet needs of patients suffering from severe heart failure, announced today that its first […]
KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Dimensions®, a leader in the development of innovative, minimally invasive treatment modalities to address patients suffering from heart failure with functional mitral regurgitation (FMR), today announced that its Carillon Mitral Contour System® has received certification under Regulation (EU) 2017/745 (“MDR”). The MDR program is intended to ensure high standards […]
